Report indicates Team Sky riders took performance-enhancing medications to win Tour de France
An explosive parliamentary report has suggested Team Sky and Bradley Wiggins used performance-enhancing medications under the guise of treating a legitimate medical condition in order to win the 2012 Tour de France.
The long-awaited report by the digital, culture, media and athletic select committee is a potential death knell for Team Sky. It calls into question exactly how they became one of the most successful outfits in British sporting history and draws a number of injury conclusions.
The most stark is that Team Sky abused the anti-doping system to allow Wiggins, and possibly support riders, to take powerful corticosteroids to prepare them for the Tour de France. It also suggests their director, Sir David Brailsford, must take responsibility for abandoning an ethos of” winning clean”, which was the genesis of Team Sky, as a hunger for victory took over.
The MPs who led the inquiry also suggest that many people find Team Sky’s story about an infamous jiffy container delivery to Wiggins at a race in 2011 to be entirely implausible. The inquiry claims it was privy to farther evidence that the package contained the corticosteroid triamcinolone and not the decongestant fluimucil, as was claimed by Team Sky. If that were ever proved to be true, and triamcinolone was administered to Wiggins at that time, it would amount to an anti-doping rule violation.
As it is, such reports found that Team Sky abused the system of therapeutic utilize exemptions( TUEs ), in effect a doctor’s note letting a banned substance to be used for the therapy of a legitimate medical condition.
” From the evidence that has been received by the committee, we believe that this powerful corticosteroid[ triamcinolone] was being used to prepare Bradley Wiggins, and maybe other riders supporting him, for the Tour de France ,” such reports reads.” The purpose of this was not to treat medical require, but to improve his power-to-weight ratio ahead of the race. The application for the TUE for the triamcinolone for Bradley Wiggins, ahead of the 2012 Tour de France, also meant that he benefited from the performance-enhancing properties of this medication during the race.
” This does not constitute a violation of the World Anti-Doping Agency code, but it does cross the ethical line that David Brailsford says he himself describe for Team Sky. In this case, and contrary to the testimony of David Brailsford in front of the committee on conferences, we believe that drugs were being used by Team Sky, within the Wada rules, to enhance the performance of riders, and not just to treat medical want .”
Wiggins said:” I find it so sad that accusations can be made, where people can be accused of things they have never done which are then regarded as facts. I strongly refute the claim that any narcotic was used without medical need.I hope to have my say in the next few days and put to my side across .”
The report focuses on inconsistencies in accounts of what was contained in a jiffy container package delivered to Wiggins and Team Sky during the Criterium du Dauphine in 2011, which is the object of a UK Anti-Doping( Ukad) investigation. Ukad shut the investigation last November after deeming it impossible to determine whether the contents were the legal decongestant fluimucil or the powerful corticosteroid triamcinolone, or something else. Dr Richard Freeman, the former Team Sky medic who ordered the package, refused to comment when asked by the DCMS committee inquiry what it was.
” To many people, the whole story of the package seems implausible, to say the least ,” the report reads.” Further info indicated to members of the committee claimed that the product that was requested to be sent out to the event was triamcinolone .”